AMAG PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 440
- Market Cap
- -
- Website
- http://www.amagpharma.com
A Crossover Safety Study of Ferumoxytol Versus Placebo
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2008-11-11
- Lead Sponsor
- AMAG Pharmaceuticals, Inc.
- Target Recruit Count
- 750
- Registration Number
- NCT00255450
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- AMAG Pharmaceuticals, Inc.
- Target Recruit Count
- 304
- Registration Number
- NCT00255437
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- AMAG Pharmaceuticals, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT00233597
© Copyright 2024. All Rights Reserved by MedPath